Pancreatic Cancer Impact in South Dakota's Native Communities
GrantID: 14414
Grant Funding Amount Low: $150,000
Deadline: Ongoing
Grant Amount High: $450,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Grant Overview
Why South Dakota is Poised to Address Pancreatic Cancer Disparities in Clinical Trials
South Dakota's unique demographic and geographic landscape presents both challenges and opportunities for increasing the recruitment and retention of underrepresented minority groups in pancreatic cancer clinical trials. The state's relatively small population, with a significant proportion of Native American communities, requires tailored approaches to outreach and engagement. The South Dakota Department of Health's Cancer Registry provides critical data for understanding the state's cancer burden and identifying areas for targeted intervention.
Leveraging Regional Strengths and Addressing Challenges
One of South Dakota's distinguishing features is its frontier geography, with many rural counties having limited access to healthcare services. This reality necessitates innovative strategies for reaching potential participants in clinical trials. The state's Native American reservations, including the Pine Ridge and Rosebud reservations, are home to a significant proportion of the state's underrepresented minority population. Collaborations between healthcare providers, tribal organizations, and community-based initiatives can help build trust and increase participation in clinical trials. For instance, the Indian Health Service (IHS) and tribal health programs can play a vital role in promoting cancer education and clinical trial awareness among Native American communities.
The Sioux Falls-based Sanford Health system and the Rapid City-based Monument Health are two major healthcare providers in the state that can leverage their resources and networks to support clinical trial recruitment and retention efforts. Additionally, organizations like the South Dakota Cancer Coalition can help facilitate partnerships and coordination among various stakeholders. By capitalizing on these regional strengths and addressing the unique challenges posed by the state's geography and demographics, South Dakota can make meaningful strides in increasing diversity in pancreatic cancer clinical trials.
South Dakota's relatively small size can also be an advantage in implementing targeted initiatives. The state's compact healthcare landscape allows for more focused efforts and easier coordination among stakeholders. For example, the South Dakota State University's Extension program has a proven track record of working with rural communities to promote health education and outreach. By partnering with such organizations, clinical trial sponsors can effectively reach and engage underrepresented populations.
To maximize the impact of their efforts, applicants should consider the specific needs and concerns of South Dakota's Native American communities. This may involve developing culturally sensitive educational materials, providing language access services, and ensuring that clinical trial staff are trained to work effectively with diverse populations. By taking a tailored approach to addressing the state's unique demographic and geographic characteristics, applicants can increase the likelihood of successful clinical trial recruitment and retention.
Building on Existing Infrastructure
The South Dakota Department of Health's existing cancer control initiatives provide a foundation for supporting clinical trial recruitment and retention efforts. The department's Comprehensive Cancer Control Plan outlines strategies for reducing cancer disparities and improving cancer outcomes across the state. By aligning clinical trial initiatives with these existing efforts, applicants can leverage established partnerships and infrastructure to achieve their goals. For example, the department's work with the South Dakota Cancer Coalition and other stakeholders has helped to identify and address cancer-related disparities in the state.
Applicants should also explore opportunities to collaborate with other organizations and initiatives in the state that are working to address cancer-related disparities. The National Institutes of Health (NIH)-funded South Dakota State University's Center for Clinical and Translational Science is one example of an initiative that can provide valuable resources and expertise to support clinical trial efforts.
Frequently Asked Questions
Q: How can applicants effectively engage with Native American communities in South Dakota to promote clinical trial awareness and participation? A: Applicants can start by building relationships with tribal leaders, healthcare providers, and community-based organizations. They should also prioritize cultural sensitivity and language access in their outreach efforts, and consider partnering with organizations that have established trust within these communities.
Q: What role can the South Dakota Department of Health play in supporting clinical trial initiatives? A: The department can provide critical data and insights on cancer trends and disparities in the state, as well as support for aligning clinical trial efforts with existing cancer control initiatives. Applicants can also leverage the department's established partnerships with other stakeholders to amplify their impact.
Q: How can applicants address the challenges posed by South Dakota's rural geography in recruiting and retaining clinical trial participants? A: Applicants can consider partnering with rural healthcare providers, using telehealth and other digital technologies to expand their reach, and developing outreach strategies that are tailored to the specific needs and concerns of rural communities.
Eligible Regions
Interests
Eligible Requirements
Related Grants
Grant to Support Innovative Research at the Intersection of HIV and Substance Use
Grant to facilitate impactful research endeavors that bridge the domains of HIV and substance use. T...
TGP Grant ID:
67005
Grants In Investing in Indigenous-Led Health Equity Research
Funding opportunities committed to providing support for Indigenous-led systematic inquiries aimed a...
TGP Grant ID:
61363
Development, Retrofitting and Construction of New Technologies
Biobased product manufacturing assistance program of up to $250 million to assist in the development...
TGP Grant ID:
21498
Grant to Support Innovative Research at the Intersection of HIV and Substance Use
Deadline :
2027-02-11
Funding Amount:
$0
Grant to facilitate impactful research endeavors that bridge the domains of HIV and substance use. This FOA seeks to attract innovative research initi...
TGP Grant ID:
67005
Grants In Investing in Indigenous-Led Health Equity Research
Deadline :
2024-03-01
Funding Amount:
$0
Funding opportunities committed to providing support for Indigenous-led systematic inquiries aimed at enhancing the health and well-being of Indigenou...
TGP Grant ID:
61363
Development, Retrofitting and Construction of New Technologies
Deadline :
2099-12-31
Funding Amount:
$0
Biobased product manufacturing assistance program of up to $250 million to assist in the development, construction, and retrofitting of new and emergi...
TGP Grant ID:
21498